1. Medtech Insight
  2. >>Device Area
  3. >>Gastroenterology

Thumbs Up: FDA Authorizes Weight Loss Suturing Systems From Apollo Endosurgery

 
• By Shawn M. Schmitt

People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.

Entrance to FDA headquarters in Maryland
• Source: Alamy

People have new tools to help them lose weight now that the US Food and Drug Administration has given the green light to suturing systems for endoscopic sleeve gastroplasty (ESG) and endoscopic bariatric revision.

The agency granted de novo authorization to Apollo Endosurgery Inc.’s Apollo ESG, Apollo ESG Sx, Apollo REVISE and Apollo REVISE Sx Systems on 13 July

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Gastroenterology

More from Device Area

Consumer Healthtech Investment Totaled $4.5BN In 2024, But Bar Is High Amid Economic Uncertainty

 
• By Marion Webb

Global investment in consumer healthtech increased by 9% year-over-year in 2024, totaling $4.5bn, with significant interest in mental health solutions, according to Galen Growth. While the first quarter of 2025 saw raised confidence and investments, the Trump administration’s new tariffs and sweeping changes to healthcare have introduced new uncertainties.

FDA And Boston Scientific Face Legal Action Over Spinal Device Safety

 
• By Elizabeth Orr

A patient, Dena Lawler, is suing Boston Scientific and the US FDA over alleged harm from a spinal stimulator device. Lawler claims inadequate regulatory review allowed dangerous modifications to the device, which then caused her pain and other health issues. She is calling for reconsideration of the device approvals.

California Medtech Firms Resolve Patent Dispute Over Delivery Catheters

 
• By Brian Bossetta

Route 92 says it has reached a settlement with Q’Apel Medical over patent claims concerning its Tenzing delivery catheters.